AeroLeads people directory · profile
Paul D. Rennert Email & Phone Number
Acting CEO, President and CSO
at
Aleta Biotherapeutics
1 work email found
@aletabio.com
3 phones found area 617 and 781
LinkedIn matched
✓ Verified August 2026
4 data sources
Profile completeness 100%
Current company
Role
Acting CEO, President and CSO
Location
Natick, Massachusetts, United States
Company size
Who is Paul D. Rennert? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Paul D. Rennert is listed as Acting CEO, President and CSO at Aleta Biotherapeutics, a with 6 employees, based in Natick, Massachusetts, United States. AeroLeads shows a work email signal at aletabio.com, phone signal with area code 617, 781, and a matched LinkedIn profile for Paul D. Rennert.
Paul D. Rennert previously worked as Acting CEO, President & CSO at Aleta Biotherapeutics and President & CSO at Aleta Biotherapeutics. Paul D. Rennert holds Multiple Degrees, Zoology, Biology from University Of Vermont.
Company email context
Email format at Aleta Biotherapeutics
This section adds company-level context without repeating Paul D. Rennert's masked contact details.
prennert@aletabio.com
79% confidence
AeroLeads found 1 current-domain work email signal for Paul D. Rennert. Compare company email patterns before reaching out.
Profile bio
About Paul D. Rennert
I am a top-tier Biotechnology Investigator and Executive with extensive strategic and leadership experience and demonstrated success in bench to IND development of small molecule and biologic drugs for oncology, autoimmunity, chronic inflammation and fibrosis. I have deep experience in therapeutic area analysis and strategic development, opportunity assessment, due diligence, and alignment of research, commercial and clinical strategies. My recent accomplishments include working intensively with CoStim Pharmaceuticals' executive team to prioritize and launch that company's Cancer Immunotherapeutics portfolio. More recently I embedded with X-Chem Inc to create X-Rx Discovery, an asset-centric biotechnology company. As CSO, I built that company from conception to full portfolio execution, including medicinal chemistry, assay development, ADME/DMPK support, efficacy and toxicity assessment. I drove two lead programs, targeting autotaxin and BTK, from hit through lead optimization, and selected lead candidates for IND enablement. More broadly, I have consulted extensively across the academic, biotechnology and venture capital environments. My contributions to corporate development include comprehensive research planning, identifying funding sources, evaluating the therapeutic rationale for pathways targeted in specific diseases (oncology, inflammation, autoimmunity, metabolic disease, cardiovascular disease, asthma and many others), review of specific molecular targets, and identifying key academic and corporate partners for specific programs. My ability to work so broadly across the bio-pharmaceutical landscape is grounded in my long and highly successful career in the industry, notably at Biogen Idec Inc.My CV may be found at www.sugarconebiotech.com
Listed skills include Immunology, Drug Development, Biotechnology, Assay Development, and 46 others.
Current workplace
Paul D. Rennert's current company
Company context helps verify the profile and gives searchers a useful next step.
Aleta Biotherapeutics
7 roles · 41 years
Paul D. Rennert work experience
A career timeline built from the work history available for this profile.
Acting Ceo, President & Cso
Current
Jan 2022 - Present
President & Cso
Jan 2016 - Feb 2022
Founder & Principal
Sugarcone Biotech Consultants Llc
2012 - 2016
~4 yrs
Chief Scientific Officer/Executive Consultant
X-Rx Discovery
X-Rx Discovery develops novel therapeutics for oncology, inflammatory and metabolic diseases. As CSO I created and executed preclinical development campaigns for a suite of stunning NCEs directed to novel targets. Critical goals include developing and managing the pipeline, building a network of collaborations that will help assess therapeutic activity, driving compound development through lead optimization and validation using in vitro, in vivo and toxicology assays and models, and building a compelling vision for the therapeutic use of X-Rx Discovery's novel drugs.
Sep 2012 - Jan 2014
Principal Scientist
Summary. Strategic, program, and project leadership, with broad responsibility for the analysis and advancement of therapeutic small molecule and biological candidate molecules, including discovery, validation and IND-enabling studies. Managed programs across Discovery Research, Medicinal and Protein Chemistry, Pre-Clinical, Clinical and Commercial operations to deliver critical analyses, linked to timelines and milestones, to enable efficient and informed program development.Recent Positions and Responsibilities.- Head, Translational ImmunoBiology Modeling- Principal Investigator, Immunobiology and Immunopharmacology - Member, Immunobiology and Rheumatology Strategic Leadership- Co-Lead, Fibrosis Strategic Review- Co-Lead, Lupus and Lupus Nephritis Strategic Area Review- Member Scientific Diligence for Biogen Idec Corporate Strategy - Lead R&D scientist, Tysabritm post-registrational studies and JC Virus mitigation - Head, Cardiovascular Inflammation Discovery
May 1995 - May 2012
Associate Scientist, Departments Of Molecular Biology And Molecular Immunology
Immunology Staff Scientist: T Cell Costimulation- Led structure/function analyses of CD28 ligands B7-1 and B7-2- Cloned and patented a novel form of CTLA4-Ig fusion protein for use in transplantation- Cloned and patented novel T cell activation proteins, fusion proteins and antibodies- Managed core facility for DNA sequencing and oligonucleotide synthesis
1986 - 1995
~9 yrs
2 education records
Paul D. Rennert education
Multiple Degrees, Zoology, Biology
University Of Vermont
Multiple Degrees, Biology, Philosophy
Colby College
FAQ
Frequently asked questions about Paul D. Rennert
Quick answers generated from the profile data available on this page.
What company does Paul D. Rennert work for?
Paul D. Rennert works for Aleta Biotherapeutics.
What is Paul D. Rennert's role at Aleta Biotherapeutics?
Paul D. Rennert is listed as Acting CEO, President and CSO at Aleta Biotherapeutics.
What is Paul D. Rennert's email address?
AeroLeads has found 1 work email signal at @aletabio.com for Paul D. Rennert at Aleta Biotherapeutics.
What is Paul D. Rennert's phone number?
AeroLeads has found 3 phone signal(s) with area code 617, 781 for Paul D. Rennert at Aleta Biotherapeutics.
Where is Paul D. Rennert based?
Paul D. Rennert is based in Natick, Massachusetts, United States while working with Aleta Biotherapeutics.
What companies has Paul D. Rennert worked for?
Paul D. Rennert has worked for Aleta Biotherapeutics, Sugarcone Biotech Consultants Llc, X-Rx Discovery, Biogen Idec, and Repligen Inc.
Who are Paul D. Rennert's colleagues at Aleta Biotherapeutics?
Paul D. Rennert's colleagues at Aleta Biotherapeutics include Kathryn Matt.
How can I contact Paul D. Rennert?
You can use AeroLeads to view verified contact signals for Paul D. Rennert at Aleta Biotherapeutics, including work email, phone, and LinkedIn data when available.
What schools did Paul D. Rennert attend?
Paul D. Rennert holds Multiple Degrees, Zoology, Biology from University Of Vermont.
What skills is Paul D. Rennert known for?
Paul D. Rennert is listed with skills including Immunology, Drug Development, Biotechnology, Assay Development, Drug Discovery, In Vitro, Clinical Development, and Pharmacology.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial